GPRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GPRE is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has bullish technical momentum and supportive analyst upgrades, but the latest quarter showed sharply weaker revenue, earnings, EPS, and margins. With no AI Stock Picker or SwingMax buy signal today, no recent news catalyst, and no insider or congressional buying support, the best call is to hold rather than buy aggressively at this level.
The chart trend is bullish in the short term. MACD histogram is positive and expanding, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. Price is trading above the pivot at 15.988 and near resistance at 17.325, with pre-market price at 17.67, which is above R1 and approaching R2 at 18.151. RSI_6 at 74.6 suggests strong momentum but also indicates the stock is already extended. Overall, the trend is upward, but the current entry is not a low-risk long-term buy point.
["Analyst sentiment has improved meaningfully over the last few months, with multiple target increases.", "Stephens upgraded the stock to Overweight and raised its target to $17, citing operational execution and earnings inflection.", "Oppenheimer and BMO both raised targets again in April/February, showing continued confidence in execution.", "The company reported strong Q4 EBITDA relative to consensus and better ethanol performance, helped by hedges and 45Z tax credits.", "The market appears to expect healthier Q1 results and resilient industry sentiment."]
["No news in the recent week, so there is no fresh event-driven catalyst right now.", "Latest quarter financials were weak, with revenue down 26.57% YoY, net income down 121.73%, EPS down 119.77%, and gross margin sharply lower.", "No recent insider buying trend and no significant hedge fund accumulation trend.", "No recent congressional trading data available.", "Similar candlestick pattern analysis suggests limited near-term upside and a meaningful chance of short-term pullback."]
In 2025 Q4, Green Plains showed weaker top-line and bottom-line performance year over year. Revenue fell to 428.8M, down 26.57% YoY. Net income dropped to 11.94M, EPS fell to 0.17, and gross margin declined sharply to 3.88. This suggests that while the business may be stabilizing operationally, the latest reported quarter did not show strong fundamental growth.
Analyst sentiment is constructive and has trended upward. Oppenheimer raised its target to $18 and kept Outperform, Stephens upgraded the stock to Overweight with a $17 target, BMO lifted its target to $15 while staying Market Perform, and UBS raised its target to $12 with a Neutral rating. The Wall Street view is mixed but improving: bulls like the operational execution, carbon credit/45Z upside, and earnings inflection, while cautious analysts still view it as only fairly valued or market-perform. Overall, pros are more positive than before, but the market still appears to be waiting for proof of sustained earnings improvement.
